| Immunological Tolerance in Patients With Mismatched Kidney Transplants (NCT05806749) | University of California, Los Angeles | 2023-07-07 |
| Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0 (NCT05965934) | Sequana Medical N.V. | 2023-07-07 |
| Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD) (NCT05618301) | Washington University School of Medicine | 2023-07-07 |
| A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors (NCT06547957) | iTeos Therapeutics | 2023-07-07 |
| A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus (NCT05917288) | GlaxoSmithKline | 2023-07-07 |
| Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes (NCT05687110) | National Cancer Institute (NCI) | 2023-07-06 |
| A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients (NCT05954988) | Rein Therapeutics | 2023-07-06 |
| SKB410 for Injection in Solid Tumors (NCT05906537) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2023-07-06 |
| Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors (NCT05985655) | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 2023-07-06 |
| Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis (NCT05944627) | Kang Stem Biotech Co., Ltd. | 2023-07-06 |
| Phase 1 Clinical Study of JMKX003142 Tablets (NCT06079541) | Jemincare | 2023-07-06 |
| Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women (NCT06217354) | Cairo University | 2023-07-06 |
| Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia (NCT05936489) | LENZ Therapeutics, Inc | 2023-07-06 |
| Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients (NCT05823571) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-07-06 |
| A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers (NCT05928585) | HI-Bio, A Biogen Company | 2023-07-06 |
| A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML (NCT05690425) | Biocity Biopharmaceutics Co., Ltd. | 2023-07-06 |
| Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics (NCT05674656) | ViiV Healthcare | 2023-07-06 |
| A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors (NCT05886374) | Hutchmed | 2023-07-06 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects. (NCT06147544) | PegBio Co., Ltd. | 2023-07-06 |
| Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels (NCT05241262) | Michio Hirano, MD | 2023-07-06 |
| Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) (NCT05853367) | Merck Sharp & Dohme LLC | 2023-07-06 |
| Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD). (NCT06175351) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-07-06 |
| Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets (NCT06558045) | Dexa Medica Group | 2023-07-06 |
| An Open-label DDI Study of Omaveloxolone in Healthy Subjects (NCT05909644) | Biogen | 2023-07-05 |
| Study in Subjects With Mild-to-Moderate Alzheimer's Dementia (NCT05834296) | Alzamend Neuro, Inc. | 2023-07-05 |
| A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (NCT05961696) | M.D. Anderson Cancer Center | 2023-07-05 |
| Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells (NCT05330130) | ART Fertility Clinics LLC | 2023-07-05 |
| Study of RPT193 in Healthy Adult Male Subjects (NCT06087978) | RAPT Therapeutics, Inc. | 2023-07-05 |
| Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects (NCT06902090) | Yangtze River Pharmaceutical Group Co., Ltd. | 2023-07-05 |
| Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease (NCT05506488) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-07-05 |
| Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors (NCT05914376) | Hangzhou Converd Co., Ltd. | 2023-07-05 |
| Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis. (NCT06038279) | Inimmune Corporation | 2023-07-04 |
| A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function (NCT05917938) | Novo Nordisk A/S | 2023-07-04 |
| Combination of CAR-DC Vaccine and ICIs in Malignant Tumors (NCT05631886) | Chinese PLA General Hospital | 2023-07-04 |
| A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants (NCT05866627) | Bristol-Myers Squibb | 2023-07-04 |
| A SHR-1210 BE Study on Healthy Subjects (NCT05799183) | Jiangsu HengRui Medicine Co., Ltd. | 2023-07-04 |
| Clinical Trial Evaluating the Safety of the TQB2103 for Injection (NCT05867563) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-07-04 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women (NCT05930704) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-07-04 |
| A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg (NCT05881707) | Chong Kun Dang Pharmaceutical | 2023-07-04 |
| Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects (NCT05902728) | Shanghai Henlius Biotech | 2023-07-04 |
| A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558 (NCT05840952) | Aligos Therapeutics | 2023-07-04 |
| Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease (NCT05948761) | Radboud University Medical Center | 2023-07-04 |
| A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors (NCT05991583) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2023-07-03 |
| An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (NCT05757570) | Alpine Immune Sciences, Inc. | 2023-07-03 |
| Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 (NCT05940298) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2023-07-03 |
| Study of SPG302 in Healthy Volunteers and ALS Participants (NCT05882695) | Spinogenix | 2023-07-03 |
| Evaluation of Bone Behavior in Maxillary Post-extractive Sites Treated With Guided Bone Regeneration (G.B.R.) Techniques in Alveolar Socket Preservation (A.S.P.) Procedures With Different Autologous and Heterologous Biomaterials. (NCT07269990) | University of Foggia | 2023-07-03 |
| A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China (NCT05949385) | Nanjing Zenshine Pharmaceuticals | 2023-07-02 |
| Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study (NCT06037239) | Peking Union Medical College Hospital | 2023-07-01 |
| An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2) (NCT05928780) | Fudan University | 2023-07-01 |
| Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers (NCT05912712) | Xijing Hospital of Digestive Diseases | 2023-07-01 |
| A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) (NCT05470140) | Allotera Therapeutics | 2023-07-01 |
| Analgesic Effect of a New Analgesic Based Gel(Douloff) Versus Oral Paracetamol in Acute Soft Injuries (NCT05647681) | University of Monastir | 2023-07-01 |
| Fruquintinib Plus Checkpoint Inhibitor Combined or Sequential TAS-102 in Colorectal Cancer Patients Who Progressed on Second-line Standard Therapy: a Prospective, Multi-cohort, Single-centered, Phase Ib/II Study (NCT07491159) | Tianjin Medical University Cancer Institute and Hospital | 2023-07-01 |
| Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (NCT03850730) | Cure HHT | 2023-07-01 |
| A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors (NCT05942378) | Fudan University | 2023-07-01 |
| Rescue Pharmacotherapy for OSA (NCT05293600) | Brigham and Women's Hospital | 2023-07-01 |
| Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas (NCT05926206) | University of Michigan Rogel Cancer Center | 2023-07-01 |
| A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies (NCT05932173) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-07-01 |
| Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus (NCT07111325) | Shanghai 6th People's Hospital | 2023-07-01 |
| Solidarity/Tokomeza Ebola Trial (NCT05909358) | Makerere University | 2023-07-01 |
| Effect of Different Doses Of Intrathecal Dexmedetomidine In Combination With Bupivacaine On Spinal Anesthesia (NCT07051512) | Tanta University | 2023-07-01 |
| Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia (NCT07065682) | Universitas Diponegoro | 2023-07-01 |
| Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor (NCT05933668) | Peking University | 2023-07-01 |
| SY007 in Patients With Acute Ischemic Stroke (NCT04891913) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2023-07-01 |
| Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma (NCT05924997) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-07-01 |
| A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity (NCT05997862) | University of Southern Mississippi | 2023-07-01 |
| Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma (NCT05909098) | Xiangyang No.1 People's Hospital | 2023-07-01 |
| Cemiplimab/Peg-Interferon-α in Advanced CSCC (NCT05729139) | Baptist Health South Florida | 2023-07-01 |
| Turmeric, Black Seeds, Flaxseed and Medicago Sativa in Knee Osteoarthritis (NCT05723458) | Tabriz University of Medical Sciences | 2023-07-01 |
| Efficacy of Roflumilast in Prevention of Peripheral Neuropathy (NCT05884281) | Mansoura University | 2023-07-01 |
| Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. (NCT06497049) | Geropharm | 2023-06-30 |
| Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors (NCT05884801) | Qilu Pharmaceutical Co., Ltd. | 2023-06-30 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors (NCT05911984) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-06-30 |
| A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors (NCT05892653) | ABM Therapeutics Shanghai Company Limited | 2023-06-30 |
| A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia (NCT04522375) | Foresee Pharmaceuticals Co., Ltd. | 2023-06-30 |
| TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL (NCT05631912) | Chinese PLA General Hospital | 2023-06-30 |
| A Study Assessing KB407 for the Treatment of Cystic Fibrosis (NCT05504837) | Krystal Biotech, Inc. | 2023-06-30 |
| The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders (NCT05865288) | Shalvata Mental Health Center | 2023-06-30 |
| A Study to Compare Two Formulations of LY3819469 in Healthy Participants (NCT05932446) | Eli Lilly and Company | 2023-06-30 |
| Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA) (NCT05898399) | Artios Pharma Ltd | 2023-06-30 |
| A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma (NCT05920876) | Qilu Pharmaceutical Co., Ltd. | 2023-06-30 |
| A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine (NCT05935033) | AbbVie | 2023-06-30 |
| Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC (NCT05663710) | M.D. Anderson Cancer Center | 2023-06-30 |
| Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity (NCT07292025) | Jetema Co., Ltd. | 2023-06-29 |
| A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib (NCT05924152) | Mirati Therapeutics Inc. | 2023-06-29 |
| RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression (NCT05940896) | RemeGen Co., Ltd. | 2023-06-29 |
| A Phase I Study of RC1416 Injection (NCT06067490) | Nanjing RegeneCore Biotech Co., Ltd. | 2023-06-29 |
| Study of GBT021601 in Participants With Renal Impairment (NCT05878704) | Pfizer | 2023-06-29 |
| Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma (NCT05625594) | City of Hope Medical Center | 2023-06-29 |
| A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants (NCT05932277) | Bristol-Myers Squibb | 2023-06-29 |
| A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors (NCT05868876) | Akeso | 2023-06-29 |
| A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009) (NCT06816030) | Merck Sharp & Dohme LLC | 2023-06-28 |
| DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors (NCT05785754) | DynamiCure Biotechnology | 2023-06-28 |
| A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL (NCT05806099) | Beijing Mabworks Biotech Co., Ltd. | 2023-06-28 |
| A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China (NCT05896774) | Pfizer | 2023-06-28 |
| Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma (NCT05853965) | Universitätsklinikum Hamburg-Eppendorf | 2023-06-28 |
| A Study Investigating Lu AG06474 in Healthy Young Participants (NCT05943327) | H. Lundbeck A/S | 2023-06-28 |
| YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT05913804) | Institute of Hematology & Blood Diseases Hospital, China | 2023-06-28 |
| A Study of DB-1202 Monotherapy in Advanced Solid Tumors (NCT05785728) | DualityBio Inc. | 2023-06-28 |